Drug Could Get Fast-Track Approval For Coronavirus Treatment

A drug that's showing promise in treating the coronavirus will reportedly be fast-tracked for approval. The F-D-A is likely to issue an emergency approval for Remdesivir. This would be the first drug approved to treat COVID-19.

At a meeting with industry executives, President Trump said he wants the FDA to act as quickly as possible. And while Dr. Anthony Fauci initially referred to the reports of treatment success as “anecdotal,” he’s on board now. Early results of a federal trial of the drug showed it may hasten the recovery from the respiratory illness.

Both the President and Dr. Fauci said they are very hopeful – and Fauci said the news coming out of Gilead Sciences, who’s behind Remdesivir, is “very promising.” Fauci noted that it is a treatment and not a prospective vaccine and said it appears that "a drug can block this virus.”

Where does the United States stand with COVID-19? At last check, there are more than 1-million cases across the United States – with 61-thousand patients succumbing to the illness – though more than 124-thousand have recovered. Globally, the numbers remains at just over 3.1-million people infected by the virus – with more than 227-thousand dead. On the plus side, more than 980-thousand have recovered.

Source: BBC News